ViroLogic, Inc.
8Patents
0Active
8Granted
27Portfolio score
Filing activity: Jan 29, 1997 → Jun 12, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5837464A | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening | Emerging Cross-Sectional Technologies | 63 | Expired |
| US6242187A | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening | Physics | 33 | Expired |
| US6351690B1 | Automated method and system for performing antiviral drug susceptibility and resistance testing | Physics | 11 | Expired |
| US6489098B1 | Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | Chemistry; Metallurgy | 7 | Expired |
| US6869759B1 | Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | Chemistry; Metallurgy | 6 | Expired |
| US6653081B2 | Methods for monitoring antiretroviral therapy and guiding therapeutic decision in the treatment of HIV/AIDS | Chemistry; Metallurgy | 5 | Expired |
| US6942969B2 | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening | Physics | 3 | Expired |
| US7037644B1 | Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.